Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.

about

Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.

Item

http://www.wikidata.org/entity/Q38810994

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Non-vitamin K-dependent oral a ...... ents with atrial fibrillation.

@en

type

Item

label

Non-vitamin K-dependent oral a ...... ents with atrial fibrillation.

@en

prefLabel

Non-vitamin K-dependent oral a ...... ents with atrial fibrillation.

@en

P1476

Non-vitamin K-dependent oral a ...... ients with atrial fibrillation

@en

P2093

Heinrich Audebert

http://www.w3.org/2001/XMLSchema#string

Karl Georg Haeusler

http://www.w3.org/2001/XMLSchema#string

Matthias Endres

http://www.w3.org/2001/XMLSchema#string

Simon Hellwig

http://www.w3.org/2001/XMLSchema#string

P2860

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Interobserver agreement for the assessment of handicap in stroke patients.

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

Confounding and confounders

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.

Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Presentation, therapy and outcome of patients with ischemic stroke under new oral anticoagulants.

Preadmission oral anticoagulant therapy and clinical outcome in patients hospitalised with acute stroke and atrial fibrillation.

Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.

P304

569-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUX087

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ulrike Grittner

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28460024

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation

P932

5889015

http://www.w3.org/2001/XMLSchema#string